A. Hargreaves

发表

Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility

M. Fornage, S. Cichon, B. Franke, 2014, Molecular Psychiatry.

Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.

M. Gill, C. Chiapponi, F. Piras, 2014, The British journal of psychiatry : the journal of mental science.

Neural effects of the CSMD1 genome‐wide associated schizophrenia risk variant rs10503253

M. Gill, A. Corvin, D. Morris, 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Social dysfunction in schizophrenia: An investigation of the GAF scale's sensitivity to deficits in social cognition

M. Gill, A. Corvin, D. Morris, 2013, Schizophrenia Research.

Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial

I. Robertson, A. Corvin, T. Wykes, 2017, Psychological Medicine.

Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.

M. Gill, R. Anney, D. Morris, 2014, JAMA psychiatry.

The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.

D. Rujescu, I. Giegling, B. Franke, 2013, The American journal of psychiatry.

ZNF804A and social cognition in patients with schizophrenia and healthy controls

M. Gill, A. Corvin, C. Fahey, 2012, Molecular Psychiatry.

Knowledge, attitudes, and behaviours towards schizophrenia, bipolar disorder, and autism: a pilot study.

Gerard M. Loughnane, A. Hargreaves, D. Mothersill, 2021, Irish journal of psychological medicine.

T69. PERFORMANCE OF PATIENTS WITH NMDAR-AB ENCEPHALITIS COMPARED TO PATIENTS WITH SCHIZOPHRENIA AND HEALTHY CONTROLS USING FUNCTIONAL MAGNETIC RESONANCE IMAGING (F-MRI) AND A WORKING MEMORY PARADIGM

A. Corvin, G. Donohoe, A. Vincent, 2018, Schizophrenia Bulletin.

Neuropsychological effects of the CSMD1 genome‐wide associated schizophrenia risk variant rs10503253

M J Owen, D. Rujescu, P. Muglia, 2013, Genes, brain, and behavior.

Computerised working memory‐based cognitive remediation therapy does not affect Reading the Mind in The Eyes test performance or neural activity during a Facial Emotion Recognition test in psychosis

I. Robertson, A. Corvin, T. Wykes, 2018, The European journal of neuroscience.

The cognitive genetics of neuropsychiatric disorders.

M. Gill, L. Gallagher, A. Corvin, 2012, Current topics in behavioral neurosciences.

The phenotypic manifestations of rare CNVs in schizophrenia

M. Gill, L. Gallagher, R. Anney, 2014, Schizophrenia Research.

Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137

J. Waddington, A. Corvin, D. Morris, 2013, Neuroscience Letters.

Variability in Working Memory Performance Explained by Epistasis vs Polygenic Scores in the ZNF 804 A

M. Gill, R. Anney, A. Corvin, 2017 .

Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia

M. Gill, A. Hargreaves, Á. Maguire, 2018, Nutritional neuroscience.

Social cognition in bipolar disorder versus schizophrenia: comparability in mental state decoding deficits

M. Gill, A. Corvin, D. Morris, 2012, Bipolar disorders.

Predictors of adherence to low support, computerised, cognitive remediation training in psychosis

I. Robertson, A. Corvin, G. Donohoe, 2018, Psychosis.

The one and the many: effects of the cell adhesion molecule pathway on neuropsychological function in psychosis

M. Gill, R. Anney, D. Morris, 2013, Psychological Medicine.

Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility

M. Fornage, S. Cichon, B. Franke, 2014, Molecular Psychiatry.

Computerised working-memory focused cognitive remediation therapy for psychosis — A preliminary study

I. Robertson, A. Corvin, G. Donohoe, 2015, Schizophrenia Research.

No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder

M. Gill, A. Hargreaves, T. McMonagle, 2021, Journal of clinical psychopharmacology.

Detecting facial emotion recognition deficits in schizophrenia using dynamic stimuli of varying intensities

A. Corvin, S. Lawless, G. Donohoe, 2016, Neuroscience Letters.

S83. THE IMPACT OF COENZYME Q10 ON THE COGNITIVE DEFICITS AND SYMPTOMS OF SCHIZOPHRENIA: PROTOCOL AND BASELINE DATA OF A RANDOMISED, PLACEBO-CONTROLLED STUDY

M. Gill, A. Hargreaves, Á. Maguire, 2018, Schizophrenia Bulletin.

Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.

M. Gill, R. Anney, D. Morris, 2014, JAMA psychiatry.

Adherence to a Low-Support Cognitive Remediation Training Program for Psychosis

I. Robertson, A. Corvin, G. Donohoe, 2016, The Journal of nervous and mental disease.

A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809

D. Rujescu, P. Muglia, I. Giegling, 2011, Schizophrenia Research.